PERSONAL DE APOYO
ORNSTEIN Ana Maria
congresos y reuniones científicas
LAUTARO ZUBELDIA-BRENNER; SANTIAGO RODRIGUEZ-SEGUI; ANA MARIA ORNSTEIN; SOFIA PERRONE
Notch Pathway Inhibition Decreases Pituitary Tumor Growth and Increases Tumor Suppressor Gene Expression in GH3 Xenografted Nude/Nude Mice
The Endocrine Society´s 99 rd Annual Meeting
Lugar: Orlando; Año: 2017;
LUQUE, G.M.; PEREZ-MILLÁN, MI; ORNSTEIN, ANA MARÍA; BECÚ,-VILLALOBOS, D.
Inhibitory effects of anti-VEGF strategies in experimental dopamine resistant prolactinomas.
The Endocrine Society´s 93 rd Annual Meeting
Lugar: Boston; Año: 2011;
GUILLERMINA MARIA LUQUE,MARIA INÉS PEREZ- MILLÁN, ANA MARIA ORNSTEIN, CAROLINA CRISTINA AND DAMASIA BECÚ- VILLALOBOS.; MARIA INÉS PEREZ- MILLÁN; ANA MARIA ORNSTEIN; RUBINSTEIN, M.; BECÚ,-VILLALOBOS, D.
Selective lactotrope dopamine D2 receptor disruption increases body weight and adipose accumulation
First Brazilian International Symposium on Integrative
Lugar: Dourado, SP; Año: 2011;
RAMIREZ, M.C.; PEREZ- MILLÁN, M.I.; ORNSTEIN, A.M.; BECÚ-VILLALOBOS,D.
Expression of liver prolactin (PRLR), growth hormone (GHR) receptors and sexually dimorphic GH-dependent genes in three mouse models with different levels of GH and PRL.
The Endocrine Society´s 93 rd Annual Meeting
Lugar: Boston; Año: 2011;